CytoMed Therapeutics Limited (GDTC)
NASDAQ: GDTC · Real-Time Price · USD
0.7600
-0.0139 (-1.80%)
Nov 17, 2026, 9:30 AM EST - Market open
CytoMed Therapeutics Employees
CytoMed Therapeutics had 42 employees as of December 31, 2025. The number of employees decreased by 1 or 2.33% compared to the previous year. That makes CytoMed Therapeutics the 35,780th largest employer in the world and 4,830th in the United States.
Employees
42
Change (1Y)
-1
Growth (1Y)
-2.33%
Revenue / Employee
$14,517
Profits / Employee
-$64,527
Market Cap
9.07M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 42 | -1 | -2.33% |
| Dec 31, 2024 | 43 | 9 | 26.47% |
| Dec 31, 2023 | 34 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| TScan Therapeutics | 138 |
| Palatin Technologies | 25 |
| BioLineRx | 24 |
| Lisata Therapeutics | 21 |
| IN8bio | 20 |
| Cellectar Biosciences | 11 |
| Purple Biotech | 10 |
| Intensity Therapeutics | 7 |
GDTC News
- 5 weeks ago - Cytomed Therapeutics receives noncompliance notification from Nasdaq - TheFly
- 7 months ago - CytoMed Therapeutics Annual report: H2 2025 - Filings
- 9 months ago - Cytomed Therapeutics refutes ‘misleading’ claims, reaffirms clinical progress - TheFly
- 10 months ago - Cytomed sees ‘enough resources’ to continue activites for ‘at least a year’ - TheFly
- 11 months ago - Cytomed Therapeutics enters into MoU with UMMC - TheFly
- 12 months ago - CytoMed completes acquisition of T cell technology of TC BioPharm - TheFly
- 1 year ago - Cytomed Therapeutics secures investment for subsidiary LongevityBank - TheFly
- 1 year ago - Cytomed Therapeutics chairman Peter Choo increases holdings to 21.95% - TheFly